297 related articles for article (PubMed ID: 25755764)
1. TGFBI protein high expression predicts poor prognosis in colorectal cancer patients.
Zhu J; Chen X; Liao Z; He C; Hu X
Int J Clin Exp Pathol; 2015; 8(1):702-10. PubMed ID: 25755764
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma.
Xi HQ; Zhao P
J Clin Pathol; 2011 Jun; 64(6):498-503. PubMed ID: 21415057
[TBL] [Abstract][Full Text] [Related]
3. Association between ezrin protein expression and the prognosis of colorectal adenocarcinoma.
Lin LJ; Chen LT
Mol Med Rep; 2013 Jul; 8(1):61-6. PubMed ID: 23708420
[TBL] [Abstract][Full Text] [Related]
4. Opposing prognostic roles of nuclear and cytoplasmic RACGAP1 expression in colorectal cancer patients.
Yeh CM; Sung WW; Lai HW; Hsieh MJ; Yen HH; Su TC; Chang WH; Chen CY; Ko JL; Chen CJ
Hum Pathol; 2016 Jan; 47(1):45-51. PubMed ID: 26508373
[TBL] [Abstract][Full Text] [Related]
5. High stromal transforming growth factor β-induced expression is a novel marker of progression and poor prognosis in gastric cancer.
Suzuki M; Yokobori T; Gombodorj N; Yashiro M; Turtoi A; Handa T; Ogata K; Oyama T; Shirabe K; Kuwano H
J Surg Oncol; 2018 Nov; 118(6):966-974. PubMed ID: 30260476
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic significance of TRAP1 expression in colorectal cancer: a large scale study of human colorectal adenocarcinoma tissues.
Pak MG; Koh HJ; Roh MS
Diagn Pathol; 2017 Jan; 12(1):6. PubMed ID: 28088229
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic and prognostic relevance of ARID1A protein loss in colorectal cancer.
Wei XL; Wang DS; Xi SY; Wu WJ; Chen DL; Zeng ZL; Wang RY; Huang YX; Jin Y; Wang F; Qiu MZ; Luo HY; Zhang DS; Xu RH
World J Gastroenterol; 2014 Dec; 20(48):18404-12. PubMed ID: 25561809
[TBL] [Abstract][Full Text] [Related]
8. Loss of stromal caveolin-1 expression in colorectal cancer predicts poor survival.
Zhao Z; Han FH; Yang SB; Hua LX; Wu JH; Zhan WH
World J Gastroenterol; 2015 Jan; 21(4):1140-7. PubMed ID: 25632186
[TBL] [Abstract][Full Text] [Related]
9. PIK3CA and PIK3CB expression and relationship with multidrug resistance in colorectal carcinoma.
Wen F; He S; Sun C; Li T; Wu S
Int J Clin Exp Pathol; 2014; 7(11):8295-303. PubMed ID: 25550888
[TBL] [Abstract][Full Text] [Related]
10. The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer.
Duncan TJ; Watson NF; Al-Attar AH; Scholefield JH; Durrant LG
World J Surg Oncol; 2007 Mar; 5():31. PubMed ID: 17349047
[TBL] [Abstract][Full Text] [Related]
11. Hierarchical investigating the predictive value of p53, COX2, EGFR, nm23 in the post-operative patients with colorectal carcinoma.
Du P; Xu B; Zhang D; Shao Y; Zheng X; Li X; Xiong Y; Wu C; Jiang J
Oncotarget; 2017 Jan; 8(1):954-966. PubMed ID: 27888614
[TBL] [Abstract][Full Text] [Related]
12. The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival.
Tsamandas AC; Kardamakis D; Ravazoula P; Zolota V; Salakou S; Tepetes K; Kalogeropoulou C; Tsota I; Kourelis T; Makatsoris T; Karavias D; Scopa CD; Bonikos DS; Kalofonos HP; Petsas T
Strahlenther Onkol; 2004 Apr; 180(4):201-8. PubMed ID: 15057430
[TBL] [Abstract][Full Text] [Related]
13. DEK over expression as an independent biomarker for poor prognosis in colorectal cancer.
Lin L; Piao J; Gao W; Piao Y; Jin G; Ma Y; Li J; Lin Z
BMC Cancer; 2013 Jul; 13():366. PubMed ID: 23902796
[TBL] [Abstract][Full Text] [Related]
14. ATAD2 overexpression is associated with progression and prognosis in colorectal cancer.
Hou M; Huang R; Song Y; Feng D; Jiang Y; Liu M
Jpn J Clin Oncol; 2016 Mar; 46(3):222-7. PubMed ID: 26819280
[TBL] [Abstract][Full Text] [Related]
15. Is there a rationale to record lymphatic invasion in node-positive colorectal cancer?
Betge J; Schneider NI; Pollheimer MJ; Lindtner RA; Kornprat P; Schlemmer A; Rehak P; Langner C
J Clin Pathol; 2012 Sep; 65(9):847-50. PubMed ID: 22569541
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of the microRNA processing enzyme Dicer is a prognostic factor in human colorectal cancer.
Faggad A; Kasajima A; Weichert W; Stenzinger A; Elwali NE; Dietel M; Denkert C
Histopathology; 2012 Oct; 61(4):552-61. PubMed ID: 22716222
[TBL] [Abstract][Full Text] [Related]
17. Thymidylate synthase and cyclin D1 protein expression in lymph node negative colorectal cancer: role as prognostic factors?
Formentini A; Henne-Bruns D; Kornmann M
Hepatogastroenterology; 2012 Sep; 59(118):1859-64. PubMed ID: 22819905
[TBL] [Abstract][Full Text] [Related]
18. Keratin 7 expression in lymph node metastases but not in the primary tumour correlates with distant metastases and poor prognosis in colon carcinoma.
Czapiewski P; Bobowicz M; Pęksa R; Skrzypski M; Gorczyński A; Szczepańska-Michalska K; Korwat A; Jankowski M; Zegarski W; Szulgo-Paczkowska A; Polec T; Piątek M; Skokowski J; Haybaeck J; Żaczek A; Biernat W
Pol J Pathol; 2016; 67(3):228-234. PubMed ID: 28155971
[TBL] [Abstract][Full Text] [Related]
19. Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance.
Yang D; Dai T; Xue L; Liu X; Wu B; Geng J; Mao X; Wang R; Chen L; Chu X
Int J Clin Exp Pathol; 2015; 8(10):13051-8. PubMed ID: 26722500
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a tumor microenvironment-based prognostic score in primary operable colorectal cancer.
Park JH; McMillan DC; Powell AG; Richards CH; Horgan PG; Edwards J; Roxburgh CS
Clin Cancer Res; 2015 Feb; 21(4):882-8. PubMed ID: 25473000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]